CYP2B7P: Enzyme in Drug Metabolism and Potential Therapeutic Target

Target Name: CYP2B7P

NCBI ID: G1556

CYP2B7P

Other Name(s): cytochrome P450 family 2 subfamily B member 7, pseudogene | CYP2B7 | Cytochrome P450 family 2 subfamily B member 7, pseudogene | CYP2B | CYP2B7P1

CYP2B7P: Enzyme in Drug Metabolism and Potential Therapeutic Target

CYP2B7P, also known as cytochrome P450 family 2 subfamily B member 7, is a gene that encodes a protein known as CYP2B7P. This gene is a member of the cytochrome P450 family, which is a large gene family that plays a crucial role in the metabolism of a wide variety of drugs and other molecules.

CYP2B7P is a pseudogene, which means that it is a gene that has been introduced into an organism at a position that is not its natural location. In the case of CYP2B7P, it is a pseudogene that is located on chromosome 19.

CYP2B7P is a key enzyme in the metabolism of many drugs, including statins, benzodiazepines, and anticancer agents. It is also a potential drug target, which means that it may be targeted by drug developers as a way to treat certain diseases.

One of the key functions of CYP2B7P is its role in the metabolism of statins. Statins are a type of drug that is used to lower cholesterol levels and reduce the risk of heart attacks and other cardiovascular problems. CYP2B7P is the enzyme that is responsible for metabolizing the active ingredient in statins, which is known as the N-hydroxy-trans-(2-methylpropyl) amine (N-OH-TMP).

In addition to its role in statin metabolism, CYP2B7P is also involved in the metabolism of other drugs and molecules. For example, it is a metabolite of the anticancer drug doxorubicin, which is used to treat various types of cancer. It is also a metabolite of the benzodiazepine drug zopiclax, which is used to treat epilepsy and other conditions.

CYP2B7P is also a potential biomarker for several diseases. For example, it is has been used as a biomarker for the diagnosis of attention-deficit/hyperactivity disorder (ADHD), which is a common disorder that affects the development of attention and self-control in children.

In addition to its role in drug metabolism, CYP2B7P is also involved in the regulation of cellular processes. For example, it is a component of the endoplasmic reticulum, which is the system that transports proteins from the ER to other parts of the cell. It is also involved in the regulation of the cytoskeleton, which is the structure that gives cells shape.

Overall, CYP2B7P is a gene that plays a crucial role in the metabolism of many drugs and other molecules. It is also a potential drug target and a potential biomarker for several diseases. Further research is needed to fully understand the role of CYP2B7P in the human body.

Protein Name: Cytochrome P450 Family 2 Subfamily B Member 7, Pseudogene

The "CYP2B7P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYP2B7P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets